Biochemical approaches to enhancement of antitumor drug selectivity: Selective protection of cells from 6-thioguanine and 6-mercaptopurine by adenosine

R. C. Jackson, D. A. Ross, R. J. Harkrader, J. Epstein

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

The cytotoxicity of 6-thioguanine and 6-mercaptopurine to cultured lymphoblasts and fibroblasts was strongly antagonized by pretreatment of the cells with 100 μM adenosine. Administration of adenosine 2 hours after the antipurine agent did not cause antagonism. In two rat hepatoma cell lines, adenosine pretreatment did not protect cells from the antipurines. Treatment of lymphoblasts or fibroblasts with 100 μM adenosine gave increases up to 150% in cellular ATP and ADP and decreases > 80% in UTP and UDP. In the hepatoma lines, adenine nucleotides did not increase by > 45%, and uridine nucleotides did not decrease by > 40% following adenosine treatment. The selective protection of the normal cells from 6-thioguanine and 6-mercaptopurine was probably the consequence of phosphoribosylpyrophosphate (PRPP) depletion, since adenosine pretreatment decreased PRPP pools by > 90% in the normal cells but by only 30% in the malignant hepatoma cells. In the absence of PRPP the antipurines would not be metabolically activated. The selectivity of the adenosine and antipurine combinations was probably attributable to the low activity of adenosine kinase and high activities of adenosine deaminase and PRPP synthetase characteristic of malignant hepatomas.

Original languageEnglish (US)
Pages (from-to)1347-1353
Number of pages7
JournalCancer Treatment Reports
Volume64
Issue number12
StatePublished - Dec 1 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Biochemical approaches to enhancement of antitumor drug selectivity: Selective protection of cells from 6-thioguanine and 6-mercaptopurine by adenosine'. Together they form a unique fingerprint.

Cite this